Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 17, Pages 4376-4381
Publisher
Proceedings of the National Academy of Sciences
Online
2017-04-11
DOI
10.1073/pnas.1616166114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimerization of Tie2 mediated by its membrane-proximal FNIII domains
- (2017) Jason O. Moore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
- (2016) Minah Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Tie1 controls angiopoietin function in vascular remodeling and inflammation
- (2016) Emilia A. Korhonen et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity
- (2016) Tomokazu Souma et al. JOURNAL OF CLINICAL INVESTIGATION
- Amelioration of sepsis by TIE2 activation–induced vascular protection
- (2016) Sangyeul Han et al. Science Translational Medicine
- Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin
- (2016) Annamarie C. Dalton et al. PLoS One
- Activation of transmembrane cell-surface receptors via a common mechanism? The “rotation model”
- (2015) Ichiro N. Maruyama BIOESSAYS
- A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner
- (2015) Nuri Oh et al. Scientific Reports
- The Orphan Receptor Tie1 Controls Angiogenesis and Vascular Remodeling by Differentially Regulating Tie2 in Tip and Stalk Cells
- (2015) Soniya Savant et al. Cell Reports
- Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
- (2014) Gabriela D’Amico et al. JOURNAL OF CLINICAL INVESTIGATION
- Architecture and Membrane Interactions of the EGF Receptor
- (2013) Anton Arkhipov et al. CELL
- Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5
- (2013) Kai Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation
- (2013) V.-M. Leppanen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region
- (2013) A. V. Reshetnyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for angiopoietin-1-mediated signaling initiation
- (2013) X. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Signal Transduction by Vascular Endothelial Growth Factor Receptors
- (2013) S. Koch et al. Cold Spring Harbor Perspectives in Medicine
- Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses
- (2012) R. Pietila et al. JOURNAL OF CELL SCIENCE
- Developmental and Pathological Angiogenesis
- (2011) Alicia S. Chung et al. Annual Review of Cell and Developmental Biology
- Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress–specific manner
- (2011) Kel Vin Woo et al. JOURNAL OF CLINICAL INVESTIGATION
- Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
- (2011) Marie Jeansson et al. JOURNAL OF CLINICAL INVESTIGATION
- VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
- (2011) Pipsa Saharinen et al. TRENDS IN MOLECULAR MEDICINE
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization
- (2010) Denis Tvorogov et al. CANCER CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Tie1-Tie2 Interactions Mediate Functional Differences between Angiopoietin Ligands
- (2010) Tom C.M. Seegar et al. MOLECULAR CELL
- Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling
- (2010) Y. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of Endothelial Tie1 Receptor Impairs Lymphatic Vessel Development-Brief Report
- (2009) Gabriela D'Amico et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oligomerized Tie2 localizes to clathrin-coated pits in response to angiopoietin-1
- (2009) Elena Bogdanovic et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
- (2009) H. T. Yuan et al. MOLECULAR AND CELLULAR BIOLOGY
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
- (2009) Hellmut G. Augustin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Differential function of Tie2 at cell–cell contacts and cell–substratum contacts regulated by angiopoietin-1
- (2008) Shigetomo Fukuhara et al. NATURE CELL BIOLOGY
- Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell–cell and cell–matrix contacts
- (2008) Pipsa Saharinen et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started